These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18790245)

  • 1. Sirolimus does not absolutely abolish the occurrence/recurrence of urothelial carcinoma in renal transplant recipients.
    Wang SM; Tai HC; Chueh SC; Chung SD; Lai MK
    Transplant Proc; 2008 Sep; 40(7):2395-6. PubMed ID: 18790245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BK virus-associated nephropathy in sirolimus-treated renal transplant patients: incidence, course, and clinical outcomes.
    Benavides CA; Pollard VB; Mauiyyedi S; Podder H; Knight R; Kahan BD
    Transplantation; 2007 Jul; 84(1):83-8. PubMed ID: 17627242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus exposure during the early post-transplant period reduces the risk of CMV infection relative to tacrolimus in renal allograft recipients.
    Haririan A; Morawski K; West MS; El-Amm JM; Doshi MD; Cincotta E; Alangaden GJ; Chandrasekar P; Gruber SA
    Clin Transplant; 2007; 21(4):466-71. PubMed ID: 17645705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma.
    Gutiérrez-Dalmau A; Sánchez-Fructuoso A; Sanz-Guajardo A; Mazuecos A; Franco A; Rial MC; Iranzo P; Torregrosa JV; Oppenheimer F; Campistol JM
    Transplant Proc; 2005 Nov; 37(9):3836-8. PubMed ID: 16386556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
    Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of neoplasm occurrence and the therapeutic effect of sirolimus in South Chinese kidney transplant recipients.
    Wang CX; Liu LS; Chen LZ; Chen SY; Wu PG; Fei JG; Qiu J; Deng SX; Zheng KL; Ji YL; Zhu LY; Shen QR; He XS
    Transplant Proc; 2006 Dec; 38(10):3536-9. PubMed ID: 17175325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies.
    Mathew T; Kreis H; Friend P
    Clin Transplant; 2004 Aug; 18(4):446-9. PubMed ID: 15233824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.
    Stephany BR; Boumitri M; Budev M; Alao B; Poggio ED
    J Heart Lung Transplant; 2009 Jun; 28(6):564-71. PubMed ID: 19481016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
    Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol conversion from a calcineurin inhibitor based therapy to sirolimus.
    Oberbauer R
    Transplantation; 2009 Apr; 87(8 Suppl):S7-10. PubMed ID: 19384186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins benefit outcomes of renal transplant recipients on a sirolimus-cyclosporine regimen.
    Lisik W; Schoenberg L; Lasky RE; Kahan BD
    Transplant Proc; 2007 Dec; 39(10):3086-92. PubMed ID: 18089328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
    Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
    Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinuria in transplant patients associated with sirolimus.
    Franco AF; Martini D; Abensur H; Noronha IL
    Transplant Proc; 2007 Mar; 39(2):449-52. PubMed ID: 17362756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus therapy in liver transplant patients: an initial experience at a single center.
    Nocera A; Andorno E; Tagliamacco A; Morelli N; Bottino G; Ravazzoni F; Casaccia M; Barocci S; Alice S; Santori G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1950-2. PubMed ID: 18675098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe limb lymphedema in sirolimus-treated patients.
    Romagnoli J; Citterio F; Nanni G; Tondolo V; Castagneto M
    Transplant Proc; 2005 Mar; 37(2):834-6. PubMed ID: 15848548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different profile of gene expression of cytokines in peripheral blood mononuclear cells of transplant recipients treated with m-TOR inhibitor and calcineurin inhibitor.
    Niemczyk M; Zegarska J; Pawłowska M; Wyzgał J; Ciszek M; Paczek L
    Transpl Immunol; 2009 Jan; 20(3):139-42. PubMed ID: 18834941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of Sirolimus in five pediatric patients undergoing solid organ transplantation].
    Roque E J; Ríos M G; Vignolo A P; Pinochet V C; Schultz M; Humeres A R; Delucchi A; Rius A M; Hepp K J
    Rev Med Chil; 2008 May; 136(5):631-6. PubMed ID: 18769812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method and outcome of transvesical ureterectomy of the distal ureter in nephroureterectomy of native kidney upper tract urothelial carcinoma ipsilateral to a transplanted kidney.
    Tseng SF; Chen YT; Cheng YT; Hsieh HH
    Urology; 2007 Jun; 69(6):1045-8. PubMed ID: 17572183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.